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Introduction: Evidence behind many of the current treatments
in hypertrophic and keloid scars remains limited. Current objec-
tive methods to assess efficacy and provide follow-up can be
complex and are not easily applied in clinical setting. The aim
of this study was to assess reliability of a recently validated
simplified technique for volume measurement in clinical
practice.
Methods: Volume measurement of 28 hypertrophic and keloid
scars was conducted in 22 consecutive patients, using a three-
dimensional stereophotogrammetry. Intra- and inter-rater relia-
bility was assessed by the intraclass correlation coefficient
(ICC) and the coefficient of variation (CV). The measurement
error was expressed as limits of agreement (LoA).
Results: The simplified method for three-dimensional volume
measurement showed good intra-rater reliability with an ICC of
0.997 and a CV of 7.3%, and a good inter-rater reliability with
an ICC of 0.999 and a CV of 5.7%. The plot of the differences
and LoA showed near-perfect agreement between observers.
Conclusion: Objective evaluation of scar volume using the
simplified three-dimensional measurement technique may com-
plement subjective scoring and improve the ability to quantita-
tively compare the response to therapeutic methods.
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HYPERTROPHIC AND keloid scars are abnormalwound responses in predisposed individu-
als, which represent a connective tissue
response to trauma, surgery, or burns (1). Scar
tissue can be distinguished from healthy skin
by an aberrant color, loss of elasticity, and con-
traction or expansion of the surface area.
Patients frequently endure functional, cosmetic,
and psychological consequences (2, 3). Effective
treatment and prevention of these pathological
scars is important, though evidence behind
many of the current treatments is limited (1).
To assess treatment response, and compare
efficacy of different treatment modalities, a reli-
able and accurate assessment tool is required
(4). Many of the scar assessment tools in current
use are semi-quantitative observer based scales
such as the Vancouver Scar Scale (5), and more
recently, the Patient and Observer Scar Assess-
ment Scale (6).
An advantage of objective assessment is that
scars can be compared quantitatively. Therefore,
these tools are usually statistically superior to a
scar scale (i.e. less subject to observer bias) (7).
Objective methods of assessment like direct
casting and the use of high-frequency ultra-
sound have some considerable limitations.
Direct casting can introduce errors in measure-
ment due to skin deformation during molding,
while ultrasound only assesses cross-sectional
depth, not the volume (8, 9).
In 2007 Taylor et al. (10) reported the use of a
non-contact 3D digitizer to measure the volume
of a keloid scar. They showed a significant posi-
tive correlation between the volume of a keloid
scar and the clinical physical severity according
to the semi-quantitative Manchester Scar Scale
(11). Ardehali et al. (12) found a near-perfect
correspondence between actual volumes of
simulated scars and those obtained using
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three-dimensional imaging. In 2015, Stekelenburg
et al. (13) found three-dimensional stereopho-
togrammetry to be suitable for the use in clini-
cal research, but not for the follow-up of the
individual patient due to too large absolute
measurement errors.
Recently, a simplified three-dimensional
volume measurement technique was validated
for simulated keloid scars (14). Thirty-three
scars were simulated using deformable model-
ing compound with variable volumes (a mean
volume of 2.884 cc), which were applied to the
sternum of subjects. The use of a flattened sur-
face for three-dimensional volume measurement
makes this technique simplified and more fit to
use in clinical practice.
This study was designed to assess the reliability
of this recently validated simplified technique in
clinical practice. Furthermore, we aim to describe
possible application of this method for objective
follow-up of hypertrophic and keloid scars.
Methods
Subjects
Subjects were recruited from the Department of
Plastic, Reconstructive, and Hand Surgery of the
University Medical Center in Maastricht, the
Netherlands. Twenty-eight hypertrophic and
keloid scars were included from 22 consecutive
patients. Causes of the scar ranged from burn,
surgery, trauma to chickenpox, or acne. Other
demographic and scar characteristics i.e. gender,
age, scar type, location of the scar, and cause of
the scar, were collected. Of all hypertrophic and
keloid scars at least one, preferably two, three-
dimensional images had to be available.
Three-dimensional imaging system
Three-dimensional capture of hypertrophic and
keloid scars was conducted using the Vectra XT
3D imaging system (Canfield Imaging Systems,
Fairfield, NJ, USA). The camera determines
points in three dimensions by triangulating
position of six color digital cameras. A three-
dimensional surface image is generated through
the principle of passive stereophotogrammetry,
where the texture of the skin is used to deter-
mine geometry (Fig. 1).
Volume measurement was done using Mirror
Analysis 3D software (Canfield Imaging Systems).
The hypertrophic or keloid scar was selected from
the three-dimensional image by pointing out the
boundaries and an enclosed surface was created.
Volume was measured using the option ‘closed
volume measurement’ (Fig. 2) (14).
Study design
Available images were retrospectively collected
from April 2013 until October 2014. Volume
measurement was performed based on the
three-dimensional images.
Several indicators were used to determine
intra-rater and inter-rater reliability of the 3D
volume measurements; the intraclass correlation
coefficient (ICC) was used to compare variabil-
ity due to measurement error with the variabil-
ity between subjects. An ICC of ≥0.90 was
considered to be acceptable for use in clinical
practice. To assess the extent of variability in
measurements in relation to the mean volume
that was measured, the coefficient of variation
(CV) was used. A CV of ≤10% was considered a
requirement for reliable results. The agreement
between observers for measuring scar volume
was displayed using Bland–Altman plots and
calculating their limits of agreement (LoA).
Data were analyzed using SPSS 20.0 software
(SPSS Inc., Chicago, IL, USA).
The study was approved by the Medical Ethi-
cal Committee of Maastricht University Medical
Center.
Results
Subject characteristics
A total of 22 patients with a consecutive 28
scars were enrolled in this study. The mean
Fig. 1. Vectra XT 3D imaging system.
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age was 27 years (range 9–69). The most com-
mon cause of the scar was surgery, with a
46%. Subject characteristics are summarized in
Table 1.
Reliability
Intra-rater reliability
The intra-rater reliability was assessed by com-
paring the results of three 3D volume measure-
ments for 28 hypertrophic or keloid scars by the
main investigator. An ICC of 0.997 with 95% CI
(0.994–0.998) was obtained for the intra-rater reli-
ability. CV had a mean of 7.3% with a minimum
of 0.8 and a maximum of 28.7% (SD = 5.6).
Inter-rater reliability
The inter-rater reliability was assessed with 3D
volume measurements of two different obser-
vers. The main investigator executed all the
measurements and the second observer, who
was blinded to the results of the main investiga-
tor, executed measurements of fifteen randomly
picked hypertrophic- and keloid scars. An ICC
of 0.999 with a 95% CI (0.997–1.000) was
obtained for the inter-rater reliability. CV had a
mean of 5.7% with a minimum of 1.6 and a
maximum of 12.1% (SD = 3.7).
A strong agreement between both observers
was seen in the Bland–Altman plot. The LoA
were mean difference  1.96 9 SD difference.
A plot that compared their measurements
showed a near-perfect correspondence (Fig. 3a
and 3b).
Fig. 2. Volume measurement using Mirror Analysis 3D software.
TABLE 1. Subject characteristics
Characteristics Value
Patients, n 22
Scars, n 28
Gender, n
Male 10
Female 12
Age, years
Mean 27
Minimum 9
Maximum 69
Scar type, n
Hypertrophic 13 (46%)
Keloid 15 (54%)
Location of the scar, n
Sternum 11 (39%)
Neck/lower jaw 5 (13%)
Other (e.g. back, thorax, knee) 12 (43%)
Cause of the scar, n
Burn 2 (7%)
Surgery 13 (46%)
Trauma 4 (14%)
Acne/chickenpox 6 (21%)
Unknown 3 (11%)
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Discussion
Various scar assessment tools have been pro-
posed and tested for their feasibility. Many of
these scales provide a measure of overall scar
quality, but tend to be subjective and observer
dependent (15, 16). An objective tool for mea-
suring scar volume is important to enable
comparison of treatment regimens and to pro-
vide objective follow-up. Current objective
methods, which include direct casting and
high-frequency ultrasound, can be complex and
are not easily applied in clinical setting (8, 9).
The use of a three-dimensional imaging system
was previously studied and showed promising
results. However, these techniques require
Fig. 3. (a) Bland–Altman plot of the volume difference between the two observers vs. the mean volume of the two Observers. (b) A plot of mea-
surements by observer two vs. measurements of observer one.
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experienced examiners and the process of com-
puterized digital reconstruction for data analy-
sis can take up to ten minutes (10, 12).
A new simplified technique using the Vectra
3D imaging system for scar assessment was
analyzed, its validity was confirmed in a previ-
ous study (14). The high ICC’s and low CV’s
found in this study indicate that the method is
extremely reliable. An additional analysis was
performed by presenting the LoA, this analysis
showed a strong agreement between the two
observers.
Three-dimensional images were captured at a
standardized manner and volumes were mea-
sured using a relatively easy method. It should
be noted that the reliability is highly dependent
on the heterogeneity of the study population,
since it is easier to distinguish between scars
with a wide range of volumes than scars with
small volume differences. However, the study
population was a good representation of the
patients as seen in clinical practice, which means
that the values for ICC en CV are representative.
The Vectra 3D imaging system is very user-
friendly; the procedure of taking a picture, pro-
cessing the data, and measuring the volume
takes approximately five minutes. Patient dis-
comfort is minimal because of the non-contact
method. The simplified technique for measuring
volume, using the boundaries of a scar to create
an enclosed surface, is more fit to use in clinical
practice. Despite these practical benefits, knowl-
edge of limitations is also important for an opti-
mal application. The Vectra 3D imaging
equipment and software are valuable, which
may be prohibitive for smaller medical centers.
The camera is a large and heavy object, which
is not very deportable. Furthermore, hair within
the area of interest can interfere with three-
dimensional reconstruction by causing artifacts.
This makes volume measurement of a scar in
this area not reliable.
Conclusion
Qualitative assessment of scars is deemed to be
useful, different parameters of subjective evalu-
ation may result in an overall impression of the
scar. For hypertrophic scars and keloids, the
most characteristic and comprehensive feature
seems to be volume. Objective evaluation of
scar volume using the simplified three-dimen-
sional measurement technique was previously
found to be valid and reliable when using
deformable modeling compound to simulate
keloids (14). This study showed high reliability
in a clinical setting. Objective evaluation of scar
volume using the simplified three-dimensional
measurement technique may complement sub-
jective scoring and improve the ability to quan-
titatively compare the response to therapeutic
methods. However, ideally large-scale prospec-
tive studies are needed to further explore the
use of the technique in clinical practice to allow
monitoring of an individual patient.
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Supporting Information
Additional Supporting Information may be found
in the online version of this article.
Video S1. Keloid scar volume measurement
using the Vectra 3D camera (Maastricht tech-
nique).
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